Cargando…
Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221730/ https://www.ncbi.nlm.nih.gov/pubmed/37243964 http://dx.doi.org/10.1007/s40264-023-01311-6 |
_version_ | 1785049526269116416 |
---|---|
author | Willame, Corinne Weibel, Daniel Sturkenboom, Miriam C. J. M. |
author_facet | Willame, Corinne Weibel, Daniel Sturkenboom, Miriam C. J. M. |
author_sort | Willame, Corinne |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10221730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-102217302023-05-30 Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” Willame, Corinne Weibel, Daniel Sturkenboom, Miriam C. J. M. Drug Saf Letter to the Editor Springer International Publishing 2023-05-27 /pmc/articles/PMC10221730/ /pubmed/37243964 http://dx.doi.org/10.1007/s40264-023-01311-6 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editor Willame, Corinne Weibel, Daniel Sturkenboom, Miriam C. J. M. Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” |
title | Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” |
title_full | Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” |
title_fullStr | Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” |
title_full_unstemmed | Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” |
title_short | Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project” |
title_sort | authors’ reply to juergen o kirchner’s comment on “incidence rates of autoimmune diseases in european healthcare databases: a contribution of the advance project” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221730/ https://www.ncbi.nlm.nih.gov/pubmed/37243964 http://dx.doi.org/10.1007/s40264-023-01311-6 |
work_keys_str_mv | AT willamecorinne authorsreplytojuergenokirchnerscommentonincidenceratesofautoimmunediseasesineuropeanhealthcaredatabasesacontributionoftheadvanceproject AT weibeldaniel authorsreplytojuergenokirchnerscommentonincidenceratesofautoimmunediseasesineuropeanhealthcaredatabasesacontributionoftheadvanceproject AT sturkenboommiriamcjm authorsreplytojuergenokirchnerscommentonincidenceratesofautoimmunediseasesineuropeanhealthcaredatabasesacontributionoftheadvanceproject |